Precision, Novartis ink potential $1.4B development deal
Durham-based Precision Biosciences has landed a new deal with Novartis that could be worth up to $1.4 billion. The NC Biotech Center has the story.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
